These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31569640)

  • 1. Host-HIV-1 Interactome: A Quest for Novel Therapeutic Intervention.
    Shukla E; Chauhan R
    Cells; 2019 Sep; 8(10):. PubMed ID: 31569640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
    Garbelli A; Riva V; Crespan E; Maga G
    Biochem J; 2017 Apr; 474(10):1559-1577. PubMed ID: 28446620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes.
    Matreyek KA; Engelman A
    Viruses; 2013 Oct; 5(10):2483-511. PubMed ID: 24103892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphorylation in the nuclear biology of HIV-1.
    Francis AC; Di Primio C; Allouch A; Cereseto A
    Curr Med Chem; 2011; 18(19):2904-12. PubMed ID: 21651489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host factors mediating HIV-1 replication.
    Friedrich BM; Dziuba N; Li G; Endsley MA; Murray JL; Ferguson MR
    Virus Res; 2011 Nov; 161(2):101-14. PubMed ID: 21871504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins.
    Chang CW; Lee CP; Su MT; Tsai CH; Chen MR
    J Virol; 2015 Feb; 89(3):1703-18. PubMed ID: 25410863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV?
    Schaller T; Herold N
    Curr HIV Res; 2016; 14(3):183-210. PubMed ID: 26957195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let me in: Control of HIV nuclear entry at the nuclear envelope.
    Bhargava A; Lahaye X; Manel N
    Cytokine Growth Factor Rev; 2018 Apr; 40():59-67. PubMed ID: 29526438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
    Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
    Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the integrase-transportin-SR2 interaction block HIV nuclear import.
    Demeulemeester J; Blokken J; De Houwer S; Dirix L; Klaassen H; Marchand A; Chaltin P; Christ F; Debyser Z
    Retrovirology; 2018 Jan; 15(1):5. PubMed ID: 29329553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 drug resistance: can we overcome?
    Brenner BG; Turner D; Wainberg MA
    Expert Opin Biol Ther; 2002 Oct; 2(7):751-61. PubMed ID: 12387674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering natural control of HIV-1: A valuable strategy to achieve antiretroviral therapy termination.
    Loucif H; Gouard S; Dagenais-Lussier X; Murira A; Stäger S; Tremblay C; Van Grevenynghe J
    Cytokine Growth Factor Rev; 2018 Apr; 40():90-98. PubMed ID: 29778137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to inhibit viral protein nuclear import: HIV-1 as a target.
    Levin A; Loyter A; Bukrinsky M
    Biochim Biophys Acta; 2011 Sep; 1813(9):1646-53. PubMed ID: 20719241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals.
    Joshi PJ; Fisher TS; Prasad VR
    Curr Drug Targets Infect Disord; 2003 Dec; 3(4):383-400. PubMed ID: 14754437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of HIV-1 capsid in viral replication and immune evasion.
    Le Sage V; Mouland AJ; Valiente-Echeverría F
    Virus Res; 2014 Nov; 193():116-29. PubMed ID: 25036886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of RNA helicase DDX3 with HIV-1 Rev-CRM1-RanGTP complex during the HIV replication cycle.
    Mahboobi SH; Javanpour AA; Mofrad MR
    PLoS One; 2015; 10(2):e0112969. PubMed ID: 25723178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells.
    Zila V; Müller TG; Laketa V; Müller B; Kräusslich HG
    mBio; 2019 Nov; 10(6):. PubMed ID: 31690677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.
    Zhan P; Liu X; De Clercq E
    Curr Med Chem; 2010; 17(6):495-503. PubMed ID: 20015032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular fatty acid synthase is required for late stages of HIV-1 replication.
    Kulkarni MM; Ratcliff AN; Bhat M; Alwarawrah Y; Hughes P; Arcos J; Loiselle D; Torrelles JB; Funderburg NT; Haystead TA; Kwiek JJ
    Retrovirology; 2017 Sep; 14(1):45. PubMed ID: 28962653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.